Peer review process
Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the editors and peer reviewers.
Read more about eLife’s peer review process.Editors
- Reviewing EditorJulien RocheIowa State University, Ames, United States of America
- Senior EditorAmy AndreottiIowa State University, Ames, United States of America
Reviewer #1 (Public review):
Summary:
Mancl et al. present an integrative structural and mechanistic analysis of the human insulin-degrading enzyme (IDE), combining cryo‑EM, time‑resolved cryo‑EM, SEC‑SAXS, enzymatic assays, all-atom molecular dynamics (MD) simulations, and coarse‑grained MD simulations. Their study delineates how IDE undergoes coordinated open-close transitions and interdomain rotations, how these motions relate to its unfoldase and protease activities, and how a single residue, R668, acts as a molecular latch governing these conformational changes. Through expanded structural datasets and computational analyses, the authors propose a mechanistic model for how IDE captures, unfolds, and degrades diverse amyloidogenic substrates such as insulin and Aβ.
Strengths:
A major strength of this study is its integration of structural, biophysical, biochemical, and computational approaches. The authors now provide six cryo‑EM structures, including a new time‑resolved O/O state captured 123 ms after substrate mixing, which clarifies the early structural response of IDE to insulin binding. The combination of multibody analysis, 3D variability analysis, all‑atom MD, and coarse‑grained Upside simulations yields a coherent picture in which rotational interdomain motions and charge‑swapping events at the IDE‑N/C interface underpin substrate unfolding and repositioning.
The identification of R668 as a central determinant of the open-close transition, supported by MD, HDX‑MS data from prior work, SEC‑SAXS, and functional assays on the R668A mutant, represents a significant mechanistic advance. The inclusion of Aβ degradation assays adds biological breadth and supports the conclusion that R668 modulates activity in a substrate‑dependent manner.
The authors have also substantially improved clarity by reorganizing figures, refining section headers, and adding introductory structural schematics. Taken together, the revised manuscript now provides a rigorous and accessible framework for understanding IDE dynamics and their relevance to amyloid peptide turnover.
Weaknesses:
At this stage, remaining limitations are modest and inherent to the system rather than the approach. While the study convincingly demonstrates substrate‑dependent modulation of IDE dynamics, it does not experimentally assess additional endogenous substrates (e.g., amylin, glucagon), which would be needed to fully generalize the role of R668 across the substrate spectrum of IDE. Furthermore, the timescale mismatch between MD simulations and catalytic turnover, which the authors clearly acknowledge, means that correlations between simulated motions and enzymatic kinetics remain inferential. Finally, some flexible cryo‑EM states (particularly O/pO) continue to exhibit moderate local resolution, which constrains atomic interpretation of highly dynamic regions, although this is addressed transparently.
Reviewer #2 (Public review):
Summary:
The manuscript describes various conformational states and structural dynamics of the Insulin degrading enzyme (IDE), a zinc metalloprotease by nature. Both open and closed state structures of IDE have been previously solved using crystallography and cryo-EM which reveal a dimeric organization of IDE where each monomer is organized into N and C domains. C-domains form the interacting interface in the dimeric protein while the two N-domains are positioned on the outer sides of the core formed by C-domains. It remains elusive how the open state is converted into the closed state but it is generally accepted that it involves large-scale movement of N-domains relative to the C-domains. Authors here have used various complementary experimental techniques such as cryo-EM, SAXS, size-exclusion chromatography and enzymatic assays to characterize the structure and dynamics of IDE protein in the presence of substrate protein insulin whose density is captured in all the structures solved. The experimental structural data from cryo-EM suffered from high degree of intrinsic motion amongst the different domains and consequently, the resultant structures were moderately resolved at 3-4.1 Å resolution. Total five structures were generated in the originally submitted manuscript using cryo-EM. Another cryo-EM reconstruction (sixth) at 5.1Å resolution was mentioned after first revision which was obtained using time-resolved cryo-EM experiments. Authors have extensively used Molecular dynamics simulation to fish out important inter-subunit contacts which involves R668, E381, D309, etc residues. In summary, authors have explored the conformational dynamics of IDE protein using experimental approaches which are complemented and analyzed in atomic detail by using MD simulation studies. The studies are meticulously conducted and lay the ground for future exploration of the protease structure-function relationship.
Strengths:
The manuscript presents a powerful integrative structural biology study that combines high-resolution cryo-EM, particle heterogeneity analysis, time-resolved cryo-EM, multiscale molecular dynamics simulations, SAXS, and biochemical assays to dissect the conformational dynamics of human insulin-degrading enzyme. A major strength is the identification of a previously unappreciated rotational component of IDE-N relative to IDE-C and the discovery of R668 as a molecular latch governing the open-close transition, supported consistently by structural, computational, mutational, and functional data. The work provides a coherent mechanistic framework linking IDE dynamics to substrate unfolding, allostery, and substrate-dependent catalysis, with clear relevance to diabetes and Alzheimer's disease biology.
Weaknesses:
Despite its depth, several key mechanistic conclusions-particularly substrate unfolding and the proposed "β-grabbing" mechanism-rely heavily on coarse-grained and all-atom MD simulations rather than direct experimental observation. Cryo-EM density for insulin is limited and heterogeneous, restricting definitive structural interpretation of substrate binding modes. The time-resolved cryo-EM experiment captures only a single dominant state at modest resolution, limiting insight into transient intermediates. In addition, the study focuses primarily on insulin, leaving the generality of the proposed mechanism for other IDE substrates insufficiently tested, and the therapeutic implications remain largely speculative without direct pharmacological modulation data.